DR. KATHERINE SELEY-RADTKE
Department of Chemistry and Biochemistry, University of Maryland, Baltimore County

Bio
Dr. Seley-Radtke earned a Ph.D. in Organic Chemistry from Auburn University, Her research involves drug discovery and development. Current research projects are focused in two areas: (i) the design and synthesis of nucleoside inhibitors of enzymes critical for replication, with a chemotherapeutic emphasis in the areas of anticancer, antiviral, and antiparasitic targets, and (ii) the use of modified nucleosides and heterocycles to explore structure and function in DNA and other biological systems. In addition to her research efforts, for the past five years Dr. Seley-Radtke has been involved with the Department of Defense and the Defense Threat Reduction Agency's collaborative effort with Russia towards the nonproliferation of biological weapons.

State Department Profile
Dr. Seley-Radtke worked in the Office of Cooperative Threat Reduction, part of the Bureau of International Security and Nonproliferation. She focused on two major projects: building biosafety and biosecurity laboratory capacity in Southeast Asia and providing an assessment of the rapidly changing landscape for science policy in Russia. As an extension of this latter project Dr. Seley-Radtke spent two additional months at the U.S. Embassy in Moscow, providing support and expertise for science and technology initiatives in Russia.